Uterine changes in transgender men receiving testosterone therapy.

Eliane Dias da SilvaRaquel Camara RiveriPoli Mara SpritzerTayane Muniz Fighera

Published in: European journal of endocrinology (2024)

In the present study, GAHT induced an atrophic condition of the endometrium in two-thirds of the transgender men, with a limited AR expression in the endometrial region. The present results suggest that testosterone-based GAHT for a mean of 5 years is safe in transgender men achieving amenorrhea.

Keyphrases

hiv testing
middle aged
replacement therapy
poor prognosis
men who have sex with men
stem cells
binding protein
oxidative stress
long non coding rna
endothelial cells
hiv infected
stress induced